000			01885 a2200457 4500
005			20250513122736.0
264		0	_c19970821
008			199708s 0 0 eng d
022			_a0003-9950
024	7		_a10.1001/archopht.1997.01100160035005 _2doi
040			_aNLM _beng _cNLM
245	0	0	_aInterferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Results of a prospective randomized placebo-controlled clinical trial. Pharmacological Therapy for Macular Degeneration Study Group. _h[electronic resource]
260			_bArchives of ophthalmology (Chicago, Ill. : 1960) _cJul 1997
300			_a865-72 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aChoroid _xblood supply
650	0	4	_aChoroid Diseases _xdiagnosis
650	0	4	_aDisease Progression
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDouble-Blind Method
650	0	4	_aFemale
650	0	4	_aFluorescein Angiography
650	0	4	_aFollow-Up Studies
650	0	4	_aFundus Oculi
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aMacular Degeneration _xcomplications
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeovascularization, Pathologic _xdiagnosis
650	0	4	_aRecombinant Proteins
650	0	4	_aSafety
650	0	4	_aTreatment Outcome
650	0	4	_aVisual Acuity
773	0		_tArchives of ophthalmology (Chicago, Ill. : 1960) _gvol. 115 _gno. 7 _gp. 865-72
856	4	0	_uhttps://doi.org/10.1001/archopht.1997.01100160035005 _zAvailable from publisher's website
999			_c9211020 _d9211020